High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples